Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT00261456
Eligibility Criteria:
Inclusion Criteria:
* Male carriers of a known pathogenic BRCA1/2 or Mismatch Repair gene mutations (MSH2, MSH6, MLH1) or men testing negative for a known BRCA1/2/ Mismatch repair mutation (MSH2, MSH6, MLH1) in their family
* Aged between 40-69 years old
* WHO performance status 0-2
* No previous history of prostate cancer
* No previous prostate biopsy for raised PSA
* Absence of any psychological, familial, sociological or geographical situation potentially hampering compliance with the study protocol and follow-up schedule
* Fully informed, written consent according to ICH/EU GCP and national/local regulations before subject registration.
Exclusion Criteria:
* Previous cancer with terminal prognosis of less than 5 years
* Previous prostate cancer
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
40 Years
Maximum Age:
69 Years
Study:
NCT00261456
Study Brief:
Protocol Section:
NCT00261456